The Evaluation and Treatment of Cervical Factor Infertility a Medical-Moral Analysis

  • Saint Louis University ROR
  • Center for Human Reproduction ROR
  • Pontifical John Paul II Institute for Studies on Marriage and Family ROR

The Linacre Quarterly, 79(4), 409-425

DOI 10.1179/002436312804827127 PMID 30082986

Abstract

The current approach to infertility of assisted reproductive technology (ART) completely misses and then bypasses the evaluation and treatment of cervical factor infertility. In contrast, the Creighton Model Fertility Care System (CrMS), a method of fertility awareness that has the unique ability to quantify cervical mucus observations, and natural procreative technology (NaProTECHNOLOGY or NPT) directly evaluate and treat cervical factor infertility. The ART treatment of choice for cervical factor infertility--intrauterine insemination (IUI)--is also morally disparate from the NPT treatment protocol: while the latter genuinely assists the infertile couple's act of sexual union to achieve its natural end of pregnancy, IUI replaces the natural act, depriving human conception of the one context worthy of the dignity of human life and procreation, a reciprocal self-gifting act of love between husband and wife. A renewed interest and focus on the direct evaluation and treatment of cervical factor infertility is needed.

Topics

cervical factor infertility treatment, NaProTechnology cervical mucus, medical moral analysis infertility, cervical mucus deficiency, intrauterine insemination alternatives, Catholic infertility treatment, cervical factor evaluation, fertility-focused intercourse, mucus enhancement therapy, procreative ethics infertility
PMID 30082986 30082986 DOI 10.1179/002436312804827127 10.1179/002436312804827127

Cite this article

Keefe, C. E., Mirkes, R., & Yeung, P. (2012). The Evaluation and Treatment of Cervical Factor Infertility a Medical-Moral Analysis. *The Linacre Quarterly*, *79*(4), 409-425. https://doi.org/10.1179/002436312804827127

Related articles